Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.
Graziani L, Gori L, Manciulli T, Basile G, Campolmi I, Borchi B, di Dio M, Mattei M, Ciurleo G, Ciliberti M, Malentacchi F, Coppi M, Morettini A, Parronchi P, Rossolini GM, Bartoloni A, Tomassetti S, Spinicci M.
Graziani L, et al. Among authors: bartoloni a.
J Antimicrob Chemother. 2023 Feb 1;78(2):555-558. doi: 10.1093/jac/dkac433.
J Antimicrob Chemother. 2023.
PMID: 36544352
Free PMC article.
No abstract available.